After analyzing the burden of leukemia in the elderly aged 60–89 years from 1990 to 2019 using the Global Burden of Disease database, we found that although the burden of chronic myeloid leukemia has decreased over the past 30 years, the burden of other types of leukemia has continued to increase to varying degrees.
Jing Wei, Qijian Feng, Ziyuan Lu
wiley +1 more source
Comparative evaluation of histopathological lesions and viral antigen distribution in domestic pigs and wild boar inoculated intranasally with the highly virulent ASFV genotype II strain "Armenia 2007". [PDF]
Wikström-Lassa E +7 more
europepmc +1 more source
The development of immunosuppression in the renal model [PDF]
Iwatsuki, S, Shaw, BW, Starzl, TE
core
Lymphatic topology reveals a novel intranodal lympho‐venous shunt
Abstract Understanding the lymphatic network is crucial for immunological research. Currently, a complete map of lymphatic drainage in mice is lacking. We present a detailed lymphatic system flow dynamic of two mouse strains with swollen lymph nodes (LNs), using region‐specific tracer injection and high‐resolution micro‐CT imaging to characterize LN ...
Ariunbuyan Sukhbaatar +5 more
wiley +1 more source
From Lymphotoxin to Tertiary Lymphoid Structures and Beyond. [PDF]
Ruddle NH.
europepmc +1 more source
Chimerism after whole organ transplantation: an explanation of renal and other organ acceptance [PDF]
Demetris, AJ +5 more
core
Abstract Enteropathogenic bacteria are a major cause of morbidity and mortality globally. While mouse models have been indispensable in advancing our understanding of infectious enteric diseases, key differences in intestinal microbiota and immunobiology between mice and humans underscore the need for alternative mammalian models that better ...
Daniel W. Hart +14 more
wiley +1 more source
Embryonic mesenchyme, mesenchymal tumors and mesenchymal stem cells: need for clarification of cell types and standardization of biomedical terminology. [PDF]
Wilting J, Becker J, Tsikolia N.
europepmc +1 more source
T‐Cell Immunity and Lung Cancer
ABSTRACT Lung cancer remains a leading cause of cancer mortality worldwide. Although immune checkpoint inhibitors (ICIs) have reshaped therapeutic strategies in lung cancer, their benefits remain limited. ICIs exert their therapeutic efficacy by activating T‐cell effector functions, underscoring the central role of T cells in antitumor immunity.
Kotaro Yamada, Yosuke Togashi
wiley +1 more source
Reprogramming Immunogenicity of Iron Oxide Nanoparticles through Sulfated Glycan Presentation
This study presents a comparative analysis of heparin (HP)‐ and dextran sulfate (DS)‐coated superparamagnetic iron oxide nanoparticles (SPIONs) as a tunable immunomodulatory platform where surface chemistry dictates therapeutic function. DS‐SPIONs are preferentially internalized by myeloid cells, reprogramming them into a pro‐healing M2 phenotype ...
Negin Pournoori +8 more
wiley +1 more source

